Published in Acta Biomater on April 06, 2013
Bone Regeneration by Nanohydroxyapatite/Chitosan/Poly(lactide-co-glycolide) Scaffolds Seeded with Human Umbilical Cord Mesenchymal Stem Cells in the Calvarial Defects of the Nude Mice. Biomed Res Int (2015) 0.75
Tough and strong porous bioactive glass-PLA composites for structural bone repair. J Mater Sci (2017) 0.75
Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials (2005) 7.55
Bone substitutes: an update. Injury (2005) 4.49
Complexity in biomaterials for tissue engineering. Nat Mater (2009) 4.38
The story of Bioglass. J Mater Sci Mater Med (2006) 2.53
Potential of ceramic materials as permanently implantable skeletal prostheses. J Biomed Mater Res (1970) 2.45
Bioactive glass in tissue engineering. Acta Biomater (2011) 2.23
A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials (2007) 1.79
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med (2008) 1.77
Bone graft substitutes. Expert Rev Med Devices (2006) 1.73
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med (2008) 1.54
Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med (2006) 1.35
Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater (2008) 1.27
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res A (2010) 1.23
Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl (2011) 1.18
Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release (2007) 1.10
The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials (2010) 1.09
MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng (2007) 1.08
Biophysical stimulation of bone fracture repair, regeneration and remodelling. Eur Cell Mater (2003) 1.05
Direct ink writing of highly porous and strong glass scaffolds for load-bearing bone defects repair and regeneration. Acta Biomater (2011) 1.03
Effect of Process Variables on the Microstructure of Hollow Hydroxyapatite Microspheres Prepared by a Glass Conversion Method. J Am Ceram Soc (2010) 0.99
Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells. J Biomed Mater Res A (2009) 0.96
Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. J Cell Physiol (2009) 0.93
Evaluation of bone regeneration, angiogenesis, and hydroxyapatite conversion in critical-sized rat calvarial defects implanted with bioactive glass scaffolds. J Biomed Mater Res A (2012) 0.93
Time for treating bone fracture using rhBMP-2: a randomised placebo controlled mouse fracture trial. J Orthop Res (2005) 0.91
Solution effects on the surface reactions of three bioactive glass compositions. J Biomed Mater Res (1993) 0.91
Hollow hydroxyapatite microspheres as a device for controlled delivery of proteins. J Mater Sci Mater Med (2011) 0.89
The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials (2006) 0.89
Surface functionalization of bioactive glasses. J Biomed Mater Res A (2009) 0.88
Bone regeneration in strong porous bioactive glass (13-93) scaffolds with an oriented microstructure implanted in rat calvarial defects. Acta Biomater (2012) 0.88
Mechanical properties of bioactive glass (13-93) scaffolds fabricated by robotic deposition for structural bone repair. Acta Biomater (2013) 0.87
Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res (1994) 0.86
Enhanced osteoblastic activity and bone regeneration using surface-modified porous bioactive glass scaffolds. J Biomed Mater Res A (2010) 0.83
Evaluation of bone regeneration in implants composed of hollow HA microspheres loaded with transforming growth factor β1 in a rat calvarial defect model. Acta Biomater (2012) 0.83
In vitro adsorption and activity of enzymes on reaction layers of bioactive glass substrates. J Biomed Mater Res (1998) 0.80
A study of the formation of amorphous calcium phosphate and hydroxyapatite on melt quenched Bioglass using surface sensitive shallow angle X-ray diffraction. J Mater Sci Mater Med (2008) 0.80
The surface functionalization of 45S5 Bioglass-based glass-ceramic scaffolds and its impact on bioactivity. J Mater Sci Mater Med (2006) 0.78
Insoluble papain prepared by adsorption on porous glass. Enzymologia (1970) 0.76
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet (2006) 7.53
Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66
Radial glia cells are candidate stem cells of ependymoma. Cancer Cell (2005) 5.21
Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol (2010) 2.85
Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell (2005) 2.75
Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J Biol Chem (2004) 2.70
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res (2012) 2.53
Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res (2005) 2.41
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. J Bone Miner Res (2013) 2.25
Bioactive glass in tissue engineering. Acta Biomater (2011) 2.23
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One (2011) 2.10
Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest (2012) 2.10
Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem (2002) 1.99
E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol (2006) 1.98
The osteocyte: an endocrine cell ... and more. Endocr Rev (2013) 1.84
Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res (2003) 1.66
Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol (2009) 1.64
Local communication on and within bone controls bone remodeling. Bone (2009) 1.59
Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J Biol Chem (2005) 1.57
Adaptation of connexin 43-hemichannel prostaglandin release to mechanical loading. J Biol Chem (2008) 1.52
Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. J Bone Miner Res (2014) 1.52
Osteocyte lacunae tissue strain in cortical bone. J Biomech (2005) 1.49
Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways. J Bone Miner Res (2010) 1.47
The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res (2011) 1.42
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity. Blood (2007) 1.39
Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med (2009) 1.39
Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J Biol Chem (2003) 1.39
Medical liability of the physician in training. Clin Orthop Relat Res (2012) 1.38
Mechanical stress-activated integrin α5β1 induces opening of connexin 43 hemichannels. Proc Natl Acad Sci U S A (2012) 1.38
Dynamics of the transition from osteoblast to osteocyte. Ann N Y Acad Sci (2010) 1.37
Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res (2011) 1.35
Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med (2006) 1.35
Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res (2011) 1.35
CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology (2003) 1.30
Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res (2010) 1.29
Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res (2011) 1.29
Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater (2008) 1.27
Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques (2012) 1.26
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab (2013) 1.26
Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs (2008) 1.26
Tissue strain amplification at the osteocyte lacuna: a microstructural finite element analysis. J Biomech (2007) 1.24
Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling. Mol Cell Biol (2010) 1.24
Freeze casting of porous hydroxyapatite scaffolds. I. Processing and general microstructure. J Biomed Mater Res B Appl Biomater (2008) 1.24
Medical malpractice in hip and knee arthroplasty. J Arthroplasty (2007) 1.23
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res A (2010) 1.23
Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets. Bone (2008) 1.20
Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C Mater Biol Appl (2011) 1.18
Erk pathways negatively regulate matrix mineralization. Bone (2006) 1.08
Fabrication and testing of silicon nitride bearings in total hip arthroplasty: winner of the 2007 "HAP" PAUL Award. J Arthroplasty (2008) 1.06
What's new in total hip arthroplasty. J Bone Joint Surg Am (2008) 1.05
Preparation of hollow hydroxyapatite microspheres. J Mater Sci Mater Med (2006) 1.03
Freeze casting of porous hydroxyapatite scaffolds. II. Sintering, microstructure, and mechanical behavior. J Biomed Mater Res B Appl Biomater (2008) 1.03
Osteocyte remodeling of the perilacunar and pericanalicular matrix. Int J Oral Sci (2009) 1.02
Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading. J Bone Miner Res (2014) 1.02
The osteoblast to osteocyte transition: epigenetic changes and response to the vitamin D3 hormone. Mol Endocrinol (2014) 1.02
Medical malpractice reform: the role of alternative dispute resolution. Clin Orthop Relat Res (2012) 1.01
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res A (2010) 1.00
Gene expression signatures of a fibroblastoid preosteoblast and cuboidal osteoblast cell model compared to the MLO-Y4 osteocyte cell model. Bone (2008) 0.99
Effect of Process Variables on the Microstructure of Hollow Hydroxyapatite Microspheres Prepared by a Glass Conversion Method. J Am Ceram Soc (2010) 0.99
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes. Life Sci (2013) 0.99
Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Am J Physiol Endocrinol Metab (2013) 0.98
Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice. Bone (2012) 0.98
Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast/early osteocyte-like cell line MLO-A5. Cells Tissues Organs (2008) 0.98
Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds. Acta Biomater (2007) 0.96
Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells. J Biomed Mater Res A (2009) 0.96
The effect of devitalized trabecular bone on the formation of osteochondral tissue-engineered constructs. Biomaterials (2008) 0.96
Preliminary evidence of early bone resorption in a sheep model of acute burn injury: an observational study. J Bone Miner Metab (2013) 0.96
Preparation and in vitro evaluation of bioactive glass (13-93) scaffolds with oriented microstructures for repair and regeneration of load-bearing bones. J Biomed Mater Res A (2010) 0.95
Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng Part A (2010) 0.95
The significance of metal staining on alumina femoral heads in total hip arthroplasty. J Arthroplasty (2007) 0.95
Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5. Methods Mol Biol (2012) 0.93
Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomater (2009) 0.93
Decreased bacteria activity on Si₃N₄ surfaces compared with PEEK or titanium. Int J Nanomedicine (2012) 0.93
Identification of osteocyte-selective proteins. Proteomics (2010) 0.93
Measurement of microstructural strain in cortical bone. Eur J Morphol (2005) 0.92
The effect of titanium surface roughening on protein absorption, cell attachment, and cell spreading. Int J Oral Maxillofac Implants (2008) 0.92
Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials (2010) 0.92
Use of rapidly mineralising osteoblasts and short periods of mechanical loading to accelerate matrix maturation in 3D scaffolds. Bone (2009) 0.92
Connexin 43 channels are essential for normal bone structure and osteocyte viability. J Bone Miner Res (2015) 0.91
In vivo outcomes of tissue-engineered osteochondral grafts. J Biomed Mater Res B Appl Biomater (2010) 0.90
Strength of hollow hydroxyapatite microspheres prepared by a glass conversion process. J Mater Sci Mater Med (2008) 0.90
Freeze extrusion fabrication of 13-93 bioactive glass scaffolds for bone repair. J Mater Sci Mater Med (2011) 0.89
Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A (2013) 0.89
Hollow hydroxyapatite microspheres as a device for controlled delivery of proteins. J Mater Sci Mater Med (2011) 0.89
Generation of a conditional null allele for Dmp1 in mouse. Genesis (2008) 0.89
Freeze-cast hydroxyapatite scaffolds for bone tissue engineering applications. Biomed Mater (2008) 0.89
Porous and strong bioactive glass (13-93) scaffolds prepared by unidirectional freezing of camphene-based suspensions. Acta Biomater (2011) 0.89
Evidence for distinct membrane receptors for 1 alpha,25-(OH)(2)D(3) and 24R,25-(OH)(2)D(3) in osteoblasts. Steroids (2002) 0.88
Bone regeneration in strong porous bioactive glass (13-93) scaffolds with an oriented microstructure implanted in rat calvarial defects. Acta Biomater (2012) 0.88
Correlation of cell strain in single osteocytes with intracellular calcium, but not intracellular nitric oxide, in response to fluid flow. J Biomech (2010) 0.87
In vivo evaluation of 13-93 bioactive glass scaffolds with trabecular and oriented microstructures in a subcutaneous rat implantation model. J Biomed Mater Res A (2010) 0.87